Urinary N-acetyl-beta-glucosaminidase (NAG) in children receiving antiepileptic drugs. 1992

C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
Department of Pediatrics, National Taiwan University Hospital, Taipei, R.O.C.

The activity of urinary N-acetyl-beta-glucosaminidase (NAG) was measured in random urines using the ratio (NAG index) of NAG to grams of urine creatinine in 102 epileptic children taking antiepileptic drugs (AEDs). A high urinary NAG index (2 SD or more above the mean for the age-matched control/normal subjects) was detected in 40 (39%, 40/102) epileptic children with AEDs. None of the 40 epileptic children with abnormal urinary NAG excretion had significant proteinuria. Among the 83 epileptic children under monotherapy, 29 cases (35%) had elevated urinary NAG excretion. Valproic acid presented the highest incidence of abnormal urinary NAG index (78%, 7/9 cases) within the monotherapy group, and the incidence was statistically significantly higher than that (26%, 14/55) in the carbamazepine group (p < 0.005). In the monotherapy group, no significant difference in serum levels of AEDs was found between children with normal urinary NAG excretion and those with abnormal. Nineteen epileptic children were treated with more than one AEDs. Eleven of them (58%, 11/19 cases) had a high urinary NAG index. The incidence of high urinary NAG index in the polytherapy group and that in monotherapy group was not significantly different (p > 0.05). This study suggests that AEDs may be potentially nephrotoxic and that urinary NAG may play a role in screening renal tubular injury in epileptic children under therapy of AEDs. Further investigation should be conducted to determine whether the effect of AEDs on renal tubular cells is or is not reversible.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000118 Acetylglucosaminidase A beta-N-Acetylhexosaminidase that catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as MUCOLIPIDOSIS and various inflammatory disorders of muscle and connective tissue. N-Acetyl-beta-D-glucosaminidase,Chitobiase,N,N-Diacetylchitobiase,N-Ac-beta-Glucosaminidase,NAGase,beta-D-Acetamido-2-Deoxyglucosidase,beta-D-N-acetylglucosaminidase,beta-N-Acetylglucosaminidase,N Ac beta Glucosaminidase,N Acetyl beta D glucosaminidase,N,N Diacetylchitobiase,beta D Acetamido 2 Deoxyglucosidase,beta D N acetylglucosaminidase,beta N Acetylglucosaminidase
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
January 1999, Pediatric neurology,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
November 2000, Archives of disease in childhood,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
January 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
January 2009, Bratislavske lekarske listy,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
June 2005, Nihon rinsho. Japanese journal of clinical medicine,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
August 2002, Nihon rinsho. Japanese journal of clinical medicine,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
April 2012, Pediatric nephrology (Berlin, Germany),
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
March 2000, Ginekologia polska,
C L Tseng, and P J Wang, and Y K Tsau, and M Y Lin, and Y Z Shen
June 1983, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!